SciBase receives additional order from Castle Biosciences, advancing the collaboration

SciBase Holding announced an additional order to accelerate its ongoing clinical study involving its AI-based dermatology detection and prevention devices. The announcement signals continued clinical-study activity and customer demand, but the provided release excerpt does not disclose the order value, study scope, timeline, or financial impact.